WK 3 NR565 HTN Lipid Protocol

WK 3 NR565 HTN Lipid Protocol

WK 3 NR565 HTN Lipid Protocol

NR565/ NR 565 Advanced Pharmacology Care of the Fundamentals Exam | Questions and Verified Answers (2023/ 2024 Update)- Chamberlain Final exam The antibiotics that are in the bacteriostatic category are: - ANSWER clindamycin, macrolides, sulfonamides, and tetracyclines. the focus of Bacteriostatic drugs - ANSWER killing the bacteria that is causing ill...

Midterm Exam: NR565/ NR 565 Advanced Pharmacology Care of the Fundamentals Exam | Questions and Verified Answers (2023/ 2024 Update)- Chamberlain Q: When is it used - ASCVD Risk Score Answer: In children a screening should be done between ages 9 and 11 and then again at ages 19 and 21. For adults every 5 years after the age of 20. Some people are at greater risk like those with diabetes and a risk score greater than 7.5% and should be screened more often Q: ezetimibe- when can it ...

Final Exam: NR565/ NR 565 Advanced Pharmacology Care of the Fundamentals Exam | Questions and Verified Answers (2023/ 2024 Update)- Chamberlain Q: What to assess for if psyllium doesn't produce a bowel movement? Answer: fecal impaction Q: What can be helpful to aid in diagnosis and treatment of IBS Answer: a diary Q: Who should receive the Tdap vaccine? Answer: Immunocompromised, cancer, HIV, high-dose glucocorticoid, pregnancy Q: True contraindication for DT...

NR565 / NR 565: Advanced Pharmacology Final Exam Questions With Answers 2023 Complete Rated A+. Metabolism - ANSWER Is the process of changing one chemical into another, and the process usually either creates or uses energy. First-Pass Metabolism - ANSWER Metabolism by the liver following oral administration of a drug. Inactivates drug so less reaches the systemic circulation. Reduces the drug before reaching the blood stream, reducing its availability. Phase I Metabolism - ANSWER Also know...

NR565- Pharmacology Exam Questions With Answers 2023 (Complete Rated A+) preclinical research - ANSWER Research of drug potential, animal testing, preparation for human testing Phase I - ANSWER Initial clinical safety studies in humans. May be as few as 10 subjects, often healthy volunteers Phase II - ANSWER The study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety Phase III - ANSWER The study drug or treatment ...

Types of DM 1. Type 1- severe insulin deficiency resulting in reduction or absence of functioning beta cells in the pancreatic islets of Langerhans. This leads to hyperglycemia due to altered metabolism of lipids, carbs, and proteins. Initial s/s of hyperglycemia. Subjective findings- polyuria, polydipsia, nocturnal enuresis and polyphagia with paradoxical weight loss, visual changes and fatigue. Objective-dehydration(poor skin turgor and dry mucous), wt loss despite normal/increase appetite, r...